|
Market Cap (24-Jun) $229,103,600 (1,730th) |
Close (30-Jun) $0.020 |
Volume (30-Jun) 31,196 |
Shortsold (26-May) 1,000,000 (0.04%) (508th) |
|
52w High $1.05 |
52w Low $0.030 |
P/E 19.69 |
EPS 0 |
BXN released this announcement to the ASX on 27 February 2023, 11:04. The announcement is not marked as price sensitive, and is 2 page(s) in length and 134.62kb in size.
You can view all announcements from BXN and see how they appear on a price chart on the announcements page.
At the date of this announcement, BXN was 0.000% short sold according to ASIC data. It was ranked the 595th most shorted stock on the ASX. It is now ranked as the 508th most shorted stock on the ASX with 0.044% of total shares short sold as of the latest reported data (26 May 2026).
| Other Recent Announcements from BXN | |
|---|---|
| Bioxyne Launches BLS Clinics - Online Healthcare | 13 June 2023, 9:05 |
| Becoming a substantial holder | 8 June 2023, 16:36 |
| Becoming a substantial holder | 31 May 2023, 17:30 |
| Becoming a substantial holder | 27 February 2023, 11:04 |
| Half Yearly Report and Accounts | 23 February 2023, 16:22 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 27 January 2023, 8:38 |
| BXN to Acquire Health & Wellness Co Breathe Life Sciences | 19 December 2022, 8:45 |
You must be logged in to post a reply.
Bioxyne 